Control of Ovulation in Pigs
Ovulation in pigs has been controlled by means of gonadotrophins and by the use of compounds which suppress normal pituitary activity. Fertility and development of eggs ovulated under these conditions have been studied. Exogenous Gonadotrophins during the Uncontrolled (Estrous Cycle Ovulation can be induced at any stage of the mstrous cycle. During the follicular phase, a single injection of pregnant mare's serum (PMS) on the fifteenth or sixteenth day will cause oestrus three to four days later and ovulation occurs spontaneously. Superovulation may be induced by doses of 750 i.u. or greater, but there is much variability in response between animals. However, a high proportion of eggs ovulated at this time can be fertilized and develop normally (Hunter 1964 (Hunter , 1966 .
By contrast, during the luteal phase or during treatment with progesterone, ovulation can be induced reliably only by injecting a luteinizing preparation such as human chorionic gonadotrophin (HCG) following stimulation with PMS (Hunter 1965 , Brinkley & Nalbandov 1962 . No oestrus occurs at this time and ovulation response to a given dose of PMS is much lower than that obtained during the follicular phase. Insemination of animals induced to ovulate when active corpora lutea are present in the ovaries leads to .many abnormalities of fertilization, especially polyspermy. Polyspermy also occurs during the follicular phase under conditions of delayed insemination (Dziuk & Polge 1962 , Hunter 1965 or if progesterone is injected shortly before ovulation (Polge & Day 1967 ), suggesting a relationship between the incidence of polyspermy and endogenous levels of progesterone.
Corpora lutea which are developed at any stage of the cycle appear to persist for about sixteen days in animals which are not pregnant (Neill & Day 1964) and it is therefore possible to use gonadotrophins to influence the rhythm of the aestrous cycle. Some degree of synchronization of the subsequent cestrus following the injection of PMS and HCG has been achieved in groups of animals (Day et al. 1965) .
Precision ofResponse to Exogenous LH The response of mature follicles to injected LH is very precise. In many hundreds of animals -examined, ovulation has occurred forty to forty-two hours following the injection of HCG (500 i.u. intramuscularly). However, precise control over the time of ovulation with HCG can be obtained only in animals which are not in oestrus at the time of injection. The onset of aestrus appears generally to coincide with an endogenous release of LH and the average time of ovulation following the onset of oestrus is also about forty hours (Chang & Polge 1967) .
The resumption of meiosis in follicular oocytes is stimulated by HCG and follows a sequence which can be determined with great accuracy. Abstriction of the first polar body does not occur until thirty-six hours after injection or shortly before ovulation (Hunter & Polge 1966) . A similar rate of development has also been observed in primary oocytes which are cultured in vitro (Edwards & Polge 1967) .
Compounds Causing Suppression ofPituitary Gonadotrophic Activity
The use of progestogens for suppressing endogenous release of pituitary gonadotrophins has been examined in pigs. Injected progesterone or orally active progestogens given at suitable dose levels will suppress cestrus and ovulation. However, large follicular cysts have been observed commonly to occur either during or following treatment and the rebound cestrus is generally not well controlled (Dziuk & Polge 1965 ). By contrast, oral administration of ICI compound 33828 will completely suppress follicular development in mature pigs when given at about 100 mg/day. Follicles do not become cystic following treatment and the occurrence of cestrus during the rebound phase is well synchronized in groups of animals. When treatment with ICI 33828 is continued for twenty days, 80-90 % of the animals come into cestrus between the fifth and seventh day following withdrawal of the drug. Ovulation occurs spontaneously during the controlled cestrus and fertility is normal (Polge 1965 .
Gonadotrophins Used in Conjunction with

ICI 33828
An extremely precise control over the time of ovulation in large groups of pigs has been achieved by the use of gonadotrophins in animals in which cestrus was previously suppressed with ICI 33828. Twenty days' treatment with ICI 33828 ensured that there were no active corpora lutea or large follicles present in any animal. One day after withdrawal, at the beginning of the induced follicular phase, a stimulating dose of PMS was given (500-1,000i.u.) and fourdays laterall animals were injected with HCG. Ovulation occurred in 100% of the animals and was controlled to an exact time by HCG. Insemination 24 hours before ovulation resulted in a conception rate of Section ofEndocrinology 655 92 % and the average litter size at three weeks of pregnancy was 9-5 which was similar to that obtained in animals untreated with gonadotrophins. Such techniques permit exact planning of a breeding programme and offer new possibilities for controlled animal production.
The Assessment of Dose Requirements of Pergonal Pergonal is a human urinary gonadotrophin preparation which has a potency of 75 i.u. FSH per ampoule. As with other FSH preparations which are used to induce follicular maturation in infertile women there is a considerable variation in individual dose requirement. We have attempted to consider some of the variables which may affect this dose requirement: (1) What response is required? (2) Is the dose requirement dependent upon clinical diagnosis? (3) Which therapeutic regime is most likely to lead to the required response ?
The answer to the first question is straightforward. The response required is a single ovulation, without hyperstimulation. More specifically the FSH preparation is required to cause maturation of a single follicle. The luteinizing stimulus, usually human chorionic gonadotrophin (HCG), is then used to induce ovulation and corpus luteum formation.
To determine whether the expected dose requirement is dependent on the clinical category of the patient, an analysis has been made of data kindly made available by Professor E M Rabau and Dr B Lunenfeld of Tel-Aviv, Israel. They have given daily injections of Pergonal, varying the dose and the duration of treatment until the patient showed evidence of follicular maturation, as judged by direct or indirect measurements of aestrogenic activity. To ensure that only treatment courses were analysed where the dose was correct, courses which failed to induce ovulation, or which led to clinical hyperstimulation, have been excluded.
We initially considered the possibility that patients may have a higher dose requirement for pregnancy to occur than for ovulation without pregnancy. Individual means were calculated for each patient from courses which were ovulatory only and those where pregnancy occurred, including only patients where both observations were available. From these values overall means were derived for ovulatory cycles and pregnancy cycles:
To induce ovulation without pregnancy (64 observations): 26-8 ampoules To induce ovulation and pregnancy (48 observations): 
ampoules
The difference between these two means is only on the borderline of statistical significance, and greater numbers are needed. For the present it seems fair to say that the actual difference is too small to be of clinical importance. The next step was to calculate the mean doses for each patient from ovulatory cycles, with or without pregnancy. From these individual means, group means were derived to show the dosage requirement in various diagnostic categories (Table 1) .
The various mean dose requirements shown in the righthand column of Table 1 were compared, using a single factor analysis of variance, and the 
